SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-082897
Filing Date
2021-03-16
Accepted
2021-03-16 16:36:00
Documents
14
Period of Report
2021-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d227782d8k.htm   iXBRL 8-K 25696
2 EX-99.1 d227782dex991.htm EX-99.1 39925
6 GRAPHIC g227782g0316092236346.jpg GRAPHIC 4036
  Complete submission text file 0001193125-21-082897.txt   201800

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cala-20210312.xsd EX-101.SCH 3072
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20210312_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20210312_pre.xml EX-101.PRE 11409
7 EXTRACTED XBRL INSTANCE DOCUMENT d227782d8k_htm.xml XML 3377
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 21746322
SIC: 2834 Pharmaceutical Preparations